NASDAQ · Biotechnology

Intellia Therapeutics Inc (NTLA)

$10.00 +5.04%
37 In band Daily RSI (14) · 18 Nov 2026

Moving averages

SMA 200$13.01-23.14%

Company profile

Intellia Therapeutics, Inc., a genome editing company, is focused on developing therapies. The company is headquartered in Cambridge, Massachusetts.

SectorHealthcare
IndustryBiotechnology
Market cap$1.60B
P/E ratioNone
EPS$-3.35
Beta1.821
Dividend yield0.00%
52-week high$18.48
52-week low$7.95

Similar stocks in Biotechnology

30 days of PRO Unlimited free, no card

RSI alerts for NTLA

An email when NTLA closes below RSI 30 or above 70. Nothing else.

Data last updated 13 November 2026 at 4:40 AM EST